Wenshi Wang1, Yijin Wang2, Changbo Qu1, Shan Wang2, Jianhua Zhou1,3, Wanlu Cao1, Lei Xu1, Buyun Ma1, Mohamad S Hakim1,4, Yuebang Yin1, Tiancheng Li5, Maikel P Peppelenbosch1, Jingmin Zhao2, Qiuwei Pan1. 1. Department of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, The Netherlands. 2. Department of Pathology and Hepatology, Beijing 302 Hospital, Beijing, People's Republic of China. 3. State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, Gansu, People's Republic of China. 4. Department of Microbiology, Faculty of Medicine, Universitas Gadjah Mada, Yogyakarta, Indonesia. 5. Department of Virology II, National Institute of Infectious Diseases, Gakuen 4-7-1 Musashi-murayama, Tokyo, Japan.
Abstract
The outcomes of hepatitis E virus (HEV) infection are diverse, ranging from asymptomatic carrier, self-limiting acute infection, and fulminant hepatitis to persistent infection. This is closely associated with the immunological status of the host. This study aimed to understand the innate cellular immunity as the first-line defense mechanism in response to HEV infection. Phosphorylation of signal transducer and activator of transcription 1, a hallmark of the activation of antiviral interferon (IFN) response, was observed in the liver tissues of the majority of HEV-infected patients but not in the liver of uninfected individuals. In cultured cell lines and primary liver organoids, we found that HEV RNA genome potently induced IFN production and antiviral response. This mechanism is conserved among different HEV strains, including genotypes 1, 3, and 7 as tested. Interestingly, single-stranded HEV RNA is sufficient to trigger the antiviral response, without the requirement of viral RNA synthesis and the generation of an RNA replicative form or replicative intermediate. Surprisingly, the m7 G cap and poly A tail are not required, although both are key features of the HEV genome. Mechanistically, this antiviral response occurs in a retinoic acid-inducible gene-I-independent, melanoma differentiation-associated protein 5-independent, mitochondrial antiviral signaling protein-independent, and β-catenin-independent but IRF3-dependent and IRF7-dependent manner. Furthermore, the integrity of the Janus kinase-signal transducer and activator of transcription pathway is essentially required. CONCLUSION: HEV infection elicits an active IFN-related antiviral response in vitro and in patients, triggered by the viral RNA and mediated by IFN regulatory factors 3 and 7 and the Janus kinase-signal transducer and activator of transcription cascade; these findings have revealed new insights into HEV-host interactions and provided the basis for understanding the pathogenesis and outcome of HEV infection. (Hepatology 2018;67:2096-2112).
The outcomes of hepatitis E virus (HEV) infection are diverse, ranging from asymptomatic carrier, self-limiting acute infection, and fulminant hepatitis to persistent infection. This is closely associated with the immunological status of the host. This study aimed to understand the innate cellular immunity as the first-line defense mechanism in response to HEV infection. Phosphorylation of signal transducer and activator of transcription 1, a hallmark of the activation of antiviral interferon (IFN) response, was observed in the liver tissues of the majority of HEV-infectedpatients but not in the liver of uninfected individuals. In cultured cell lines and primary liver organoids, we found that HEV RNA genome potently induced IFN production and antiviral response. This mechanism is conserved among different HEV strains, including genotypes 1, 3, and 7 as tested. Interestingly, single-stranded HEV RNA is sufficient to trigger the antiviral response, without the requirement of viral RNA synthesis and the generation of an RNA replicative form or replicative intermediate. Surprisingly, the m7 G cap and poly A tail are not required, although both are key features of the HEV genome. Mechanistically, this antiviral response occurs in a retinoic acid-inducible gene-I-independent, melanoma differentiation-associated protein 5-independent, mitochondrial antiviral signaling protein-independent, and β-catenin-independent but IRF3-dependent and IRF7-dependent manner. Furthermore, the integrity of the Janus kinase-signal transducer and activator of transcription pathway is essentially required. CONCLUSION:HEV infection elicits an active IFN-related antiviral response in vitro and in patients, triggered by the viral RNA and mediated by IFN regulatory factors 3 and 7 and the Janus kinase-signal transducer and activator of transcription cascade; these findings have revealed new insights into HEV-host interactions and provided the basis for understanding the pathogenesis and outcome of HEV infection. (Hepatology 2018;67:2096-2112).
Authors: Harini Sooryanarain; C Lynn Heffron; Hassan M Mahsoub; Anna M Hassebroek; Bo Wang; Debin Tian; S Ansar Ahmed; Xiang-Jin Meng Journal: J Virol Date: 2022-09-14 Impact factor: 6.549
Authors: Andrea Beer; Heidemarie Holzmann; Sven Pischke; Patrick Behrendt; Fritz Wrba; Jerome Schlue; Uta Drebber; Barbara Neudert; Emina Halilbasic; Hans Kreipe; Ansgar Lohse; Martina Sterneck; Heiner Wedemeyer; Michael Manns; Hans P Dienes Journal: Liver Int Date: 2019-06-17 Impact factor: 5.828
Authors: Pengfei Li; Yunlong Li; Yijin Wang; Jiaye Liu; Marla Lavrijsen; Yang Li; Ruyi Zhang; Monique M A Verstegen; Yining Wang; Tian-Cheng Li; Zhongren Ma; Denis E Kainov; Marco J Bruno; Robert A de Man; Luc J W van der Laan; Maikel P Peppelenbosch; Qiuwei Pan Journal: Sci Adv Date: 2022-01-19 Impact factor: 14.136